Long-term iron accumulation in dialysis patients treated with ferric citrate hydrate: a single-center, 80-week retrospective study in Japan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2059-1381
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Long-term iron accumulation in dialysis patients treated with ferric citrate hydrate: a single-center, 80-week retrospective study in Japan ; volume:3 ; number:1 ; day:5 ; month:9 ; year:2017 ; pages:1-8 ; date:12.2017
Renal replacement therapy ; 3, Heft 1 (5.9.2017), 1-8, 12.2017
- Schlagwort
-
Urologische Chirurgie
- Urheber
-
Hiratsuka, Maki
- Beteiligte Personen und Organisationen
-
Koyama, Katsushi
Sengo, Kinya
Yamamoto, Jun
Narita, Aiko
Ito, Chiharu
Kominato, Satoshi
Hibi, Arata
Kamiya, Keisuke
Miyahara, Rumi
Fujikawa, Junichi
Miura, Toshiyuki
SpringerLink (Online service)
- DOI
-
10.1186/s41100-017-0118-7
- URN
-
urn:nbn:de:1111-201710285634
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hiratsuka, Maki
- Koyama, Katsushi
- Sengo, Kinya
- Yamamoto, Jun
- Narita, Aiko
- Ito, Chiharu
- Kominato, Satoshi
- Hibi, Arata
- Kamiya, Keisuke
- Miyahara, Rumi
- Fujikawa, Junichi
- Miura, Toshiyuki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Ferric pyrophosphate citrate: interactions with transferrin
Physicochemical characterization of ferric pyrophosphate citrate
Antiviral effects of ferric ammonium citrate
Ferric Citrate Hydrate Has Little Impact on Hyperplasia of Enterochromaffin Cells in the Rat Small Intestine Compared to Sodium Ferrous Citrate
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Ferric pyrophosphate citrate: interactions with transferrin
Physicochemical characterization of ferric pyrophosphate citrate
Antiviral effects of ferric ammonium citrate
Ferric Citrate Hydrate Has Little Impact on Hyperplasia of Enterochromaffin Cells in the Rat Small Intestine Compared to Sodium Ferrous Citrate
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial
Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study
Cost-effectiveness of ferric citrate hydrate in patients with iron deficiency anemia
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
Ferric pyrophosphate citrate: interactions with transferrin
Physicochemical characterization of ferric pyrophosphate citrate
Antiviral effects of ferric ammonium citrate
Ferric Citrate Hydrate Has Little Impact on Hyperplasia of Enterochromaffin Cells in the Rat Small Intestine Compared to Sodium Ferrous Citrate
Individualized anemia management enhanced by ferric pyrophosphate citrate protocol
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
Correction: Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
A review of ferric citrate clinical studies, and the rationale and design of the Ferric Citrate and Chronic Kidney Disease in Children (FIT4KiD) trial